Abstract:Background Restoration of blood flow to the ischemic liver lobes may paradoxically exacerbate tissue injury, which is called hepatic ischemia/reperfusion injury (IRI). Toll-like receptor 4 (TLR4), expressed on several liver cell types, and the nuclear factor-kappa B (NF-kappa B) signaling pathway are crucial to mediating hepatic inflammatory response. Because IRI is essentially a kind of profound acute inflammatory reaction evoked by many kinds of danger signals, we investigated TLR4/NF-kappa B signaling pathway activation in a murine model of partial hepatic IRI.Methods Wild-type mice (WT, C3H/HeN) or TLR4 mutant mice (C3H/HeJ) were subjected to 45 minutes of partial hepatic ischemia followed by 1 hour, 3 hours of reperfusion. Sham group accepted the same procedure without the obstruction of blood supply. At the end of reperfusion, the compromise of liver function and the histological change of liver sections were measured as the severity of liver injury. The level of endotoxin in the portal vein was measured by limulus assay. NF-kappa B activation was determined by electrophoretic mobility shift assay (EMSA). The levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-10) in systemic blood after hepatic IRI were assessed by enzyme-linked immunosorbent assay (ELISA).Results The compromise of liver function and the morphological injuries in mutant mice were relieved more markedly than those in WT mice after partial hepatic IRI. NF-kappa B activation in WT mice was stronger than that in TLR4 mutant mice, and both were stronger than those in the sham operated mice (P < 0.01). Endotoxin in each group was undetectable. The levels of TNF-a and IL-10 in systemic blood were elevated in both strains, but lower in the sham operated group. These mediators were significantly decreased in TLR4 mutant mice compared with those in WT mice (P < 0.01).Conclusions The TLR4/NF-kappa B signaling pathway may mediate hepatic IRI triggered by endogenous danger signals. Inhibition of the TLR4/NF-kappa B pathway may be a potential therapeutic target for attenuating ischemia/reperfusion-induced tissue damage in some clinicalsettings.

The Hepatic Nerves Regulated Inflammatory Effect in the Process of Liver Injury: Is Nerve the Key Treating Target for Liver Inflammation?

Neuroimmune modulation in liver pathophysiology

The Roles Of Innate Immune Cells In Liver Injury And Regeneration

Current Perspectives of Neuroendocrine Regulation in Liver Fibrosis

Influence of Hepatic Innate Immunity on Liver Regeneration

Infectious Microecology in Liver Disease

Natural Killer T Cells Play a Necessary Role in Modulating of Immune-Mediated Liver Injury by Gut Microbiota

Relevance of mast cells and hepatic lobule innervation to liver injury

Targeting the Hepatic Microenvironment to Improve Ischemia/Reperfusion Injury: New Insights into the Immune and Metabolic Compartments

Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury

Damage‐associated Molecular Pattern–activated Neutrophil Extracellular Trap Exacerbates Sterile Inflammatory Liver Injury

Neurotrophic factors stimulate the activation of hepatic stellate cells in liver fibrosis

Hepatic Nervous System in Development, Regeneration, and Disease

Hepatic inflammation and fibrosis: Functional links and key pathways

Research progress on liver injury in acute pancreatitis

Inflammation in the Peripheral Nervous System after Injury

Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis

Endogenous Danger Signals Trigger Hepatic Ischemia/Reperfusion Injury Through Toll-Like Receptor 4/nuclear Factor-Kappa B Pathway

The Injury-Related Activation of Hedgehog Signaling Pathway Modulates the Repair-Associated Inflammation in Liver Fibrosis

Hepatic stellate cell activation markers are regulated by the vagus nerve in systemic inflammation

Role of Immuno-Inflammatory Signals in Liver Ischemia-Reperfusion Injury